OPRD1 Antikörper (pSer363) (FITC)
Kurzübersicht für OPRD1 Antikörper (pSer363) (FITC) (ABIN2690258)
Target
Alle OPRD1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pSer363
-
Verwendungszweck
- Phospho-delta Opioid Receptor (Ser363) Polyclonal Antibody, FITC Conjugated
-
Spezifität
- This phosphorylation site is homologous in the listed cross reactive species at the specified location.
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Cow,Chicken,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human OPRD1 around the phosphorylation site of TP(p-S)DG
-
Isotyp
- IgG
-
-
anti-Opioid Receptor, delta 1 (OPRD1) (AA 2-18), (Extracellular), (N-Term) antibody
OPRD1 Reaktivität: Maus WB, IHC, FACS, IF, IC, LCI Wirt: Kaninchen Polyclonal unconjugated
anti-Opioid Receptor, delta 1 (OPRD1) antibodyOPRD1 Reaktivität: Human WB, FACS, ICC Wirt: Kaninchen Monoclonal 24GB280 unconjugated Recombinant Antibody
anti-Opioid Receptor, delta 1 (OPRD1) (AA 81-180) antibodyOPRD1 Reaktivität: Human WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Opioid Receptor, delta 1 (OPRD1) (pSer363) antibodyOPRD1 Reaktivität: Human WB, FACS, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Opioid Receptor, delta 1 (OPRD1) (C-Term) antibodyOPRD1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Opioid Receptor, delta 1 (OPRD1) antibodyOPRD1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Monoclonal 7G7 unconjugated Recombinant Antibody
anti-Opioid Receptor, delta 1 (OPRD1) (C-Term) antibodyOPRD1 Reaktivität: Human, Affe IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Opioid Receptor, delta 1 (OPRD1) (Extracellular Domain) antibodyOPRD1 Reaktivität: Human, Affe, Hund, Pferd, Kaninchen IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Opioid Receptor, delta 1 (OPRD1) antibodyOPRD1 Reaktivität: Human WB Wirt: Kaninchen Monoclonal unconjugated
anti-Opioid Receptor, delta 1 (OPRD1) (AA 323-372), (pSer363) antibodyOPRD1 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB(1:300-5000), FCM(1:20-100), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- OPRD1 (Opioid Receptor, delta 1 (OPRD1))
-
Andere Bezeichnung
- OPRD1
-
Hintergrund
-
Synonyms: OPRD, Delta-type opioid receptor, D-OR-1, DOR-1, OPRD1
Background: G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.
-
Gen-ID
- 4985
-
UniProt
- P41143
-
Pathways
- Protein targeting to Nucleus
Target
-
